Probiotics for bloating: what the research actually shows

Here's the short version first: a few specific probiotic strains have reduced bloating in individual trials, but when researchers pool all the evidence, their confidence drops considerably. Both halves of that sentence matter if you're deciding whether to try one.

Below is what the major reviews and some key trials found, and how to use that information without falling for either the hype or the blanket dismissal.

The big picture: many trials, low certainty

The largest recent analysis pooled 82 randomized trials with 10,332 adults with IBS. Only 24 of those trials were at low risk of bias across every area assessed. For abdominal bloating or distension, there was only very low certainty evidence of a benefit, for combination probiotics and for Bacillus strains. The risk of side effects was not significantly higher with probiotics than with placebo (Goodoory et al., 2023).

The American Gastroenterological Association's technical review reached a similar conclusion for IBS overall. It counted 44 different probiotics or combinations that had been tested, most in just one trial, and concluded that no single strain or combination had been studied rigorously enough. The panel also found registered studies that never published results, a possible sign of publication bias (Preidis et al., 2020).

Why single trials can look better than the pooled evidence

Some individual studies do show clear improvements in bloating:

• Lactiplantibacillus plantarum 299v. In a 4-week double-blind trial with 214 adults with IBS, abdominal pain severity and frequency were lower than with placebo, with similar results for bloating. At week 4, 78.1% of people taking the strain rated its effect as excellent or good, compared with 8.1% on placebo (Ducrotté et al., 2012).
• Lactobacillus acidophilus NCFM with Bifidobacterium lactis Bi-07. In 60 people with functional bowel disorders who took the combination twice a day, at 200 billion CFU per day in total, bloating scores were lower than with placebo at 4 weeks (4.10 vs 6.17), and the change in bloating severity was still significantly better at 8 weeks (Ringel-Kulka et al., 2011).

But when researchers combine several trials of the same strain, the results can shift. A strain-specific meta-analysis published in early 2026 pooled six trials of L. plantarum 299v. It found lower abdominal pain severity, and more people reporting meaningful improvement in pain and overall digestive symptoms. It did not find a significant effect on bloating severity scores (Maslennikov et al., 2026).

The same analysis found that one strain, Bacillus coagulans Unique IS2, did reduce bloating when its trials were combined, although that was based on only two studies. Several other strains showed no effect on bloating at all (Maslennikov et al., 2026).

Why the evidence is so hard to pin down

Part of the problem is how differently probiotic trials are run. The AGA panel pointed out that results are hard to interpret because of a lack of standardization, differences in study design, trials that don't separate people by IBS subtype, and differences in dose and treatment length (Preidis et al., 2020).

Quality is the other part. With only 24 of 82 trials at low risk of bias in the largest analysis (Goodoory et al., 2023), a handful of small positive studies can look more convincing on their own than they do once everything is weighed together. And because the choice of which probiotic to test has been largely empiric, many strains have only ever had one trial (Preidis et al., 2020).

What this means in plain terms

• "Probiotics help bloating" is too broad. Results depend on the strain, and many strains show nothing.
• "Probiotics don't work" is too broad, too. Some strains have positive trials, and side effects in trials weren't significantly more common than with placebo (Goodoory et al., 2023).
• Most of this research is in IBS. If your bloating isn't related to IBS, the results may not apply in the same way.
• Trial participants may not look like you. In the NCFM and Bi-07 study, 72% of participants were women, with an average age of 37 (Ringel-Kulka et al., 2011). None of the trials described here reported results separately for women in perimenopause or after menopause.

If you decide to try one

1. Pick a strain with at least one trial that measured bloating, at a dose close to what was studied.
2. Set a fixed window. The single trials above ran for 4 to 8 weeks. Plan on 8 to 12 weeks of daily use before you decide.
3. Measure the same way throughout. Score your bloating from 0 to 10 at the same time of day, a few days a week.
4. Keep everything else steady so you can tell what's making the difference.
5. Stop if it's clearly not helping. A negative result for your gut is still a useful result.

It also helps to look at the whole product, not just the headline strain. If a probiotic adds fermentable fibers like inulin or chicory root, you may be testing two things at once. And if a strain's positive trial used a much higher dose, or a twice-daily schedule like the NCFM and Bi-07 study, a lower-dose product isn't a like-for-like test of that research (Ringel-Kulka et al., 2011).

For more on timing, see how long a probiotic takes to work. And if fermentable fibers could be part of your problem, read why inulin can make bloating worse.

When bloating needs a doctor, not a probiotic

See your doctor before trying supplements if your bloating is new and happens most days, especially with early fullness, pelvic or abdominal pain, or urinary urgency. The same goes for blood in your stool, unexplained weight loss, anemia, symptoms that wake you at night, trouble swallowing or persistent vomiting.

A family history of colon cancer, inflammatory bowel disease or celiac disease is also a good reason to get checked first, rather than starting with a supplement.

Sources

1. Goodoory VC, Khasawneh M, Black CJ, Quigley EMM, Moayyedi P, Ford AC. Efficacy of probiotics in irritable bowel syndrome: systematic review and meta-analysis. Gastroenterology. 2023;165(5):1206-1218. PMID 37541528
2. Preidis GA, Weizman AV, Kashyap PC, Morgan RL. AGA technical review on the role of probiotics in the management of gastrointestinal disorders. Gastroenterology. 2020;159(2):708-738.e4. PMID 32531292
3. Ducrotté P, Sawant P, Jayanthi V. Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome. World J Gastroenterol. 2012;18(30):4012-8. PMID 22912552
4. Ringel-Kulka T, Palsson OS, Maier D, et al. Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: a double-blind study. J Clin Gastroenterol. 2011;45(6):518-25. PMID 21436726
5. Maslennikov R, Gosteeva E, Ananeva V, et al. Strain-specific systematic review with meta-analysis of probiotics efficacy in the treatment of irritable bowel syndrome. J Clin Med. 2026;15(3):1152. PMID 41682832

This article is for general information and isn't medical advice. Talk to your healthcare provider about bloating that is new, persistent or comes with other symptoms, and before starting a supplement if you take prescription medication.